LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers for ...
sales of nearly 8.67 billion Danish kroner (around $1.2 billion). Meanwhile, generic drug makers have already sought out to capitalize on liraglutide’s success. Teva launched an authorized ...
Hosted on MSN27d
FDA Issues 4th Oyster Warning In 18 Days: Latest Advisory In Washington Over Norovirus OutbreaksThe Food and Drug Administration issued an oyster recall Thursday—its fourth in three weeks, after hundreds have been left sick—warning against the eating of certain oysters harvested in ...
On January 1, pharmaceutical companies will also lower some of their prices. The list price of Merck & Co.'s heavily discounted diabetes medications Januvia and Janumet will be lowered "to align the ...
HealthDay News — The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss medication tirzepatide is over. Tirzepatide ...
Many diabetes patients have experienced lowered drug costs in recent years, thanks to policies that have capped the price of diabetes prescriptions. For patients who have been paying for Ozempic or ...
As more consumers take GLP-1 drugs such as Ozempic and Wegovy, changing appetites are squeezing sales for some food and beverage items. The Cornell and Numerator study noted that a 6% decline in ...
In November 2024, a regulatory advisory board said the benefits of Zynquista does not outweigh the risks in adults with type 1 diabetes and chronic kidney disease. The FDA has issued a complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback